Skip to main content
. 2021 Aug 3;55:107374. doi: 10.1016/j.carpath.2021.107374

Table 4.

Secondary Outcomes by Level of Cardiac Troponin Elevation

Mild cTn Elevation, > 1 to < 2x ULN Severe cTn Elevation, ≥ 2x ULN P -value
n 69 46
Readmitted (%) 10 (14.5) 2 (4.3) 0.152
In-Hospital Mortality or Readmission (%) 26 (37.7) 22 (47.8) 0.375
Admitted to ICU (%) 38 (55.1) 35 (76.1) 0.036
Required ICU During Admission (%) 47 (68.1) 41 (89.1) 0.017
ECMO (%) 3 (4.3) 3 (6.7) 0.910
Tracheostomy (%) 8 (11.6) 3 (6.7) 0.585
Required Pressors (%) 30 (43.5) 35 (76.1) 0.001
Required Inotropes (%) 4 (5.8) 11 (23.9) 0.011
Total 60-Day MAE (%) 30 (43.5) 27 (58.7) 0.159
PE (%) 5 (7.2) 7 (15.2) 0.290
DVT (%) 4 (5.8) 7 (15.2) 0.174
Renal Replacement Therapy (%) 11 (15.9) 14 (30.4) 0.106
Life-threatening Arrhythmia (%) 12 (17.4) 12 (26.1) 0.373
Stroke (%) 0 (0.0) 0 (0.0) 1.000
Acute HF Exacerbation (%) 4 (5.8) 6 (13.0) 0.311

cTn = cardiac troponin; ULN = upper limit of normal; ICU = intensive care unit; ECMO = extracorporeal membrane oxygenation, MAE = major adverse event; PE = pulmonary embolism; DVT = deep venous thrombosis